Inflammation and Cognitive Decline in Autoimmune Diseases

Autoimmune diseases arise when the immune system erroneously targets self-tissues, leading to chronic systemic inflammation. Such persistent inflammation is increasingly recognised as a driver of cognitive decline, from mild memory impairment to dementia. Circulating pro-inflammatory cytokines can compromise the blood–brain barrier and activate central glial cells. Microglial and astrocytic responses may induce synaptic loss, neuronal dysfunction and accumulation of neurotoxic proteins traditionally associated with Alzheimer’s disease. Clinical studies report higher rates of cognitive deficits among patients with rheumatoid arthritis, inflammatory bowel disease and systemic lupus erythematosus, suggesting a common inflammatory contribution to neural damage. Experimental models corroborate these observations, showing that peripheral inflammatory insults accelerate neurodegenerative processes through alterations in the gut–brain axis and glial atrophy. Unravelling shared molecular pathways, including key genetic regulators and peripheral biomarkers, promises novel interventions to protect cognitive health in individuals with autoimmune conditions.

Research from Nature Portfolio

Recent systematic reviews and genetic analyses have interrogated the relationship between rheumatoid arthritis and Alzheimer’s disease. Meta-analyses of epidemiological cohorts indicate a lower incidence of Alzheimer’s among rheumatoid arthritis patients, while large-scale Mendelian randomisation using genome-wide data finds no evidence of a direct causal link. This discrepancy suggests that confounding factors, such as anti-inflammatory medication use or diagnostic bias, may underlie observed associations rather than intrinsic autoimmune mechanisms.

Inflammation and Cognitive Decline in Autoimmune Diseases publication trend

The graph below shows the total number of articles in inflammation and cognitive decline in autoimmune diseases across all publications each year (not limited to Nature Index journals).

Technical terms

Systemic inflammation: Ongoing activation of the immune system throughout the body, mediated by pro-inflammatory cytokines.

Neuroinflammation: Inflammatory processes within the brain and spinal cord involving glial cell activation and cytokine release.

Cytokine: A signalling protein released by immune cells that regulates inflammation and intercellular communication.

Astrocyte: A star-shaped glial cell in the central nervous system that supports neuronal function and maintains the blood–brain barrier.

Microglia: Resident immune cells of the central nervous system that respond to injury by clearing debris and releasing inflammatory mediators.

Gut–brain axis: The bidirectional communication network between the gastrointestinal tract and the central nervous system, involving neural, hormonal and immune pathways.

Mendelian randomisation: A method using genetic variants as proxies for risk factors to assess causal relationships with disease outcomes.

References

1. Exposure to autoimmune disorders is associated with increased Alzheimer’s disease risk in a multi-site electronic health record analysis. Cell Reports Medicine (2025).
2. Experimental colitis in young Tg2576 mice accelerates the onset of an Alzheimer’s-like clinical phenotype. Alzheimer's Research & Therapy (2024).
3. Shared Genes of PPARG and NOS2 in Alzheimer’s Disease and Ulcerative Colitis Drive Macrophages and Microglia Polarization: Evidence from Bioinformatics Analysis and Following Validation. International Journal of Molecular Sciences (2023).
4. Rheumatoid arthritis and risk for Alzheimer’s disease: a systematic review and meta-analysis and a Mendelian Randomization study. Scientific Reports (2017).